171 – 180 of 1423
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
-
Mark
Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive decline
(
- Contribution to journal › Article
-
Mark
Survey among experts on the future role of tau-PET in clinical practice and trials
(
- Contribution to journal › Article
-
Mark
Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
(
- Contribution to journal › Article
-
Mark
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals
(
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease
2024) In Value in Health(
- Contribution to journal › Article